1. Home
  2. LPRO vs EOLS Comparison

LPRO vs EOLS Comparison

Compare LPRO & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Open Lending Corporation

LPRO

Open Lending Corporation

HOLD

Current Price

$3.12

Market Cap

368.0M

Sector

Finance

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.78

Market Cap

407.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPRO
EOLS
Founded
2000
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
368.0M
407.0M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
LPRO
EOLS
Price
$3.12
$6.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$2.58
$15.50
AVG Volume (30 Days)
5.1M
752.5K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
96.46
1.23
EPS
N/A
N/A
Revenue
N/A
$297,176,000.00
Revenue This Year
$10.58
$13.27
Revenue Next Year
$14.01
$17.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.61
52 Week Low
$1.18
$3.86
52 Week High
$3.13
$10.20

Technical Indicators

Market Signals
Indicator
LPRO
EOLS
Relative Strength Index (RSI) 74.93 53.63
Support Level $1.28 $6.44
Resistance Level N/A $6.95
Average True Range (ATR) 0.04 0.31
MACD 0.02 -0.01
Stochastic Oscillator 98.62 39.44

Price Performance

Historical Comparison
LPRO
EOLS

About LPRO Open Lending Corporation

Open Lending Corp is a provider of lending enablement and risk analytics to credit unions, regional banks, finance companies and the captive finance companies of automakers (OEM captive finance companies). Through its flagship product, LPP, its customers, collectively referred to herein as automotive lenders or lenders, make automotive consumer loans to underserved near-prime and non-prime borrowers by harnessing its risk-based interest rate pricing models, powered by its proprietary data and real-time underwriting of automotive loan default insurance coverage from insurers.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: